Stereotactic ablative radiotherapy (SABR) may offer potential benefit for patients with oligometastatic cancers. The SABR technology is still evolving, and there is still uncertainty about whether or not this treatment will be effective.
Detecting prostate cancer early in men at risk is of prostate cancer can potentially improve outcomes. Prostate specific antigen (PSA) testing, however, has been shown to not be an effective method of detecting prostate cancer in the population.
It is known that ultraviolet light exposure causes melanoma. However, it is not clear whether there are other environmental factors acting along with ultraviolet radiation. This study investigates the role of organochlorine compounds, found in the environment, in melanoma development.
This multi- institute project (InterMEL consortium project) identifies molecular and clinical factors which relate to the prognosis of melanoma, with the ultimate objective of improving the treatment of advanced melanoma.
Polarization speckle is a noise-like interference pattern created when a skin lesion is illuminated by laser light.
In this project, we develop a handheld and easy-to-operate optical probe for detecting melanoma. Delivery of the technology is aimed at non-dermatologist healthcare providers, improving their diagnostic accuracy and reducing the number of referrals to the specialists.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.